Abstract
SummaryComparing the gonadotropic response of the organism to subcutaneous or intraperitoneal administration of pregnancy urine prolan the following results were secured: (1) If the minimum dose is split up into 6 portions intraperitoneal and subcutaneous administration are equally effective. (2) If the minimum dose is split up into 3 portions the intraperitoneal route is approximately half as effective as the subcutaneous one. (3) If the minimum dose is given in one injection the intraperitoneal administration is about 1/10 as effective as subcutaneous. (4) Using the subcutaneous standardization method with minute doses as e.g., 1 RU (estrous effect) the gonadotropic effect of 6 subthreshold doses is less marked than that of one single threshold dose.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
